These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 8471519

  • 1. Bullous eruption of systemic lupus erythematosus: a clinicopathological study of four cases.
    Burrows NP, Bhogal BS, Black MM, Rustin MH, Ishida-Yamamoto A, Kirtschig G, Russell Jones R.
    Br J Dermatol; 1993 Mar; 128(3):332-8. PubMed ID: 8471519
    [Abstract] [Full Text] [Related]

  • 2. Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen.
    Gammon WR, Woodley DT, Dole KC, Briggaman RA.
    J Invest Dermatol; 1985 Jun; 84(6):472-6. PubMed ID: 3889170
    [Abstract] [Full Text] [Related]

  • 3. Bullous eruption of SLE--a case report and investigation of the relationship of anti-basement-membrane-zone antibodies to blistering.
    Burge S, Schomberg K, Wojnarowska F.
    Clin Exp Dermatol; 1991 Mar; 16(2):133-8. PubMed ID: 2032377
    [Abstract] [Full Text] [Related]

  • 4. Bullous disease in systemic lupus erythematosus.
    Rappersberger K, Tschachler E, Tani M, Wolff K.
    J Am Acad Dermatol; 1989 Oct; 21(4 Pt 1):745-52. PubMed ID: 2681283
    [Abstract] [Full Text] [Related]

  • 5. Alterations of basement membrane zone in autoimmune subepidermal bullous diseases.
    Woźniak K, Kowalewski C.
    J Dermatol Sci; 2005 Dec; 40(3):169-75. PubMed ID: 15990279
    [Abstract] [Full Text] [Related]

  • 6. Detection of anti-basement membrane zone antibodies in bullous systemic lupus erythematosus.
    Janniger CK, Kowalewski C, Mahmood T, Lambert WC, Schwartz RA.
    J Am Acad Dermatol; 1991 Apr; 24(4):643-7. PubMed ID: 2033145
    [Abstract] [Full Text] [Related]

  • 7. Systemic lupus erythematosus with vesiculobullous lesions. Immunoelectron microscopic studies.
    Tani M, Shimizu R, Ban M, Murata Y, Tamaki A.
    Arch Dermatol; 1984 Nov; 120(11):1497-501. PubMed ID: 6388508
    [Abstract] [Full Text] [Related]

  • 8. Autoimmunity to type VII collagen.
    Woodley DT, Sarret Y, Briggaman RA.
    Semin Dermatol; 1991 Sep; 10(3):232-9. PubMed ID: 1931572
    [Abstract] [Full Text] [Related]

  • 9. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin.
    Gammon WR, Briggaman RA, Inman AO, Queen LL, Wheeler CE.
    J Invest Dermatol; 1984 Feb; 82(2):139-44. PubMed ID: 6363567
    [Abstract] [Full Text] [Related]

  • 10. Linear IgA disease with clinical and immunopathological features of epidermolysis bullosa acquisita.
    Mutasim DF, Cummings MP.
    Pediatr Dermatol; 1997 Feb; 14(4):303-6. PubMed ID: 9263315
    [Abstract] [Full Text] [Related]

  • 11. Bullous systemic lupus erythematosus responding to dapsone.
    Ludgate MW, Greig DE.
    Australas J Dermatol; 2008 May; 49(2):91-3. PubMed ID: 18412808
    [Abstract] [Full Text] [Related]

  • 12. Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder.
    Gammon WR, Briggaman RA.
    J Invest Dermatol; 1993 Jan; 100(1):28S-34S. PubMed ID: 8423389
    [Abstract] [Full Text] [Related]

  • 13. Vesiculobullous systemic lupus erythematosus. A report of four cases.
    Camisa C.
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 1):93-100. PubMed ID: 3279084
    [Abstract] [Full Text] [Related]

  • 14. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
    Ishikawa O, Zaw KK, Miyachi Y, Hashimoto T, Tanaka T.
    Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736
    [Abstract] [Full Text] [Related]

  • 15. Bullous systemic lupus erythematosus with milia and calcinosis.
    Eckman JA, Mutasim DF.
    Cutis; 2002 Jul; 70(1):31-4. PubMed ID: 12184671
    [Abstract] [Full Text] [Related]

  • 16. Bullous systemic lupus erythematosus: detection of antibodies against noncollagenous domain of type VII collagen.
    Shirahama S, Furukawa F, Yagi H, Tanaka T, Hashimoto T, Takigawa M.
    J Am Acad Dermatol; 1998 May; 38(5 Pt 2):844-8. PubMed ID: 9591800
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa.
    Minato H, Ishii N, Fukuda S, Wakasa T, Wakasa K, Sogame R, Hashimoto T, Horiguchi Y.
    J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683
    [Abstract] [Full Text] [Related]

  • 18. Bullous systemic lupus erythematosus: an unusual clinical course and detectable circulating autoantibodies to the epidermolysis bullosa acquisita antigen.
    Barton DD, Fine JD, Gammon WR, Sams WM.
    J Am Acad Dermatol; 1986 Aug; 15(2 Pt 2):369-73. PubMed ID: 3525621
    [Abstract] [Full Text] [Related]

  • 19. Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen.
    Gammon WR, Briggaman RA.
    Dermatol Clin; 1993 Jul; 11(3):535-47. PubMed ID: 8365038
    [Abstract] [Full Text] [Related]

  • 20. Bullous systemic lupus erythematosus with cutaneous mucinosis and leukocytoclastic vasculitis.
    Tsuchida T, Furue M, Kashiwado T, Ishibashi Y.
    J Am Acad Dermatol; 1994 Aug; 31(2 Pt 2):387-90. PubMed ID: 8034811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.